გახანგრძლივებული QT ინტერვალის სინდრომი
DOI:
https://doi.org/10.52340/spectri.2024.09.01.10Abstract
Long QT interval syndrome (LQT) is a heterogeneous group of cardiac electrophysiological disorders characterized by prolongation of the QT interval and T-tooth abnormalities on the ECG. It is usually associated with syncope, however, it can cause sudden cardiac death due to torsade de pointes-type ventricular tachycardia. LQT is a clinical diagnosis and should be suspected based on clinical presentation, family history, and ECG features. Its management is focused on preventing syncope and ultimately sudden death. Treatment includes lifestyle modification, beta blockers, and ICD implantation are most important in the proper management of patients with LQT. There is a need to raise awareness of possible circumstances that may increase the risk of QT prolongation. Age, hypokalemia, history of heart failure, and structural heart disease are often cited in this context. An accurate assessment of the condition is required before recommending ICD implantation in a young, active patient. Medical and/or device therapy remains an important therapeutic approach in the management of patients with LQT. Bench-to-bedside insights have helped to advance better therapeutic strategies. In addition, continued progress in the fundamental understanding of the mechanisms of ion channel function and the knowledge of drug interactions on the channels is a prerequisite for success in the treatment of LQT.
Downloads
References
Congenital Long QT Syndrome, Coinciding With Cavitary Mycobacterium avium Lung Infection, Led to Cardiac Arrest, 2023, JACC: Case Reports;
Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant, 2023, Stem Cell Research;
Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000; 21:1216.
Roden DM, Lazzara R, Rosen M, et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation 1996; 94:1996;
Viskin S, Alla SR, Barron HV, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996; 28:1262;
Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981.
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.